Scott A K, Haynes B P, Schinkel K D, Ohnhaus E E, Park B K
Department of Medicine and Therapeutics, University of Aberdeen, Scotland.
Eur J Clin Pharmacol. 1987;33(1):93-5. doi: 10.1007/BF00610388.
We have studied the effect of hepatic enzyme induction on vitamin K1 elimination in patients on long-term anticonvulsant therapy and in volunteers given rifampicin. Neither the anticonvulsants (phenytoin and phenobarbitone) nor rifampicin had any significant effect on vitamin K1 elimination half-life or AUC. The neonatal haemorrhage which occurs in babies born to mothers on long-term enzyme inducing drugs is unlikely to be related to an increased rate of vitamin K elimination in the mother.
我们研究了肝酶诱导对长期接受抗惊厥治疗的患者以及服用利福平的志愿者体内维生素K1消除的影响。抗惊厥药(苯妥英和苯巴比妥)和利福平对维生素K1的消除半衰期或药时曲线下面积均无显著影响。母亲长期服用酶诱导药物的新生儿出血不太可能与母亲体内维生素K消除率增加有关。